Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 1, 1999, Pages 111-118

  Shimada, S ^a   Tashima, S ^a   Yamaguchi, K ^a   Matsuzaki, H ^a   Ogawa, M ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

'de novo' carcinoma; Adenoma carcinoma sequence; Colorectal carcinoma; Gastric carcinoma; Glycogen phosphorylase; Intestinal metaplasia; P53

Indexed keywords

BIOLOGICAL MARKER; BRAIN ENZYME; GLYCOGEN PHOSPHORYLASE; PROTEIN P53;

CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BRAIN; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DNA PRIMERS; FETUS; HUMANS; ISOENZYMES; PHOSPHORYLASES; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032926363     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Cori C.F., Cori G.T.: Mechanism and formation of hexose-monophosphate in muscle and isolation of a new phosphate ester. Proc. Soc. Exp. Biol. Med. 34: 702-712. 1936.
2. Davis C.H., Schliselfeld L.H., Wolf D.P., Leavitt C.A., Krebs E.G.: Interrelationships among glycogen phosphorylase isozymes. J. Biol. Chem. 242: 4824-4833. 1967.
3. Newgard C.B., Hwang P.K., Fletterick R.J.: The family of glycogen phosphorylase: structure and function. Crit. Rev. Biochem. Mol. Biol. 24: 69-99. 1989.
4. Shimada S., Maeno M., Akagi M., Hatayama I., Sato T., Sato K.: Immunohistochemical detection of glycogen phosphorylase isoenzymes in rat and human tissues. Histochem. J. 18: 334-338. 1986.
5. Nakano K., Hwang P., Fletterick R.J.: Complete cDNA sequence for rabbit muscle glycogen phosphorylase. FEBS Lett. 204: 283-287, 1986.
6. Newgard C.B., Littman D.R., Genderen C.V., Smith M., Fletterick R.J.: Human brain glycogen phosphorylase. J. Biol. Chem. 263: 3850-3857, 1988.
7. Sato K., Morris H.P., Weinhouse S.: Phosphorylase: a new isozyme in rat hepatic tumors and fetal liver. Science 178: 879-881. 1972.
8. Shimada S., Maeno M., Misumi A., Takano S., Akagi M.: Antigen reversion of glycogen phosphorylase isoenzyme in carcinoma and proliferative zone of intestinal metaplasia of the human stomach. Gastroenterology 93: 35-40. 1987.
9. Gelinas R.P., Froman B.E., McElroy F., Tait R.C., Gorin F.A.: Human brain glycogen phosphorylase: characterization of fetal cDNA and genomic sequence. Mol. Brain Res. 6: 177-185. 1989.
10. Takashi M., Koshikawa T., Kurobe N., Kato K.: Elevated concentrations of brain type glycogen phosphorylase in renal cell carcinoma. Jpn. J. Cancer. Res. 80: 975-980. 1989
11. Hashimoto K., Tamura K., Otani H., Tanaka O., Histochemical and immunohistochemical studies related to the role of glycogen in human developing digestive organs. Anat. Embryol. 192: 497-505. 1995
12. Shimada S., Maeno M., Misumi A., Akagi M.: Histochemical study of phosphorylase in proliferating cells of intestinal metaplasia and carcinoma of the human stomach. Scand. J. Gastroenterol. 19: 965-970. 1984.
13. Shimada S., Honmyo U., Yagi Y., Ikeda T., Yokota T., Ogawa M.: Expression of glycogen phosphorylase activity in minute gastric carcinoma. Am. J. Gastroenterol. 87: 1230-1231. 1992
14. Matsuzaki H., Shimada S., Uno K., Tsuruta J., Ogawa M.: Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis. Am. J. Clin. Pathol. 109: 181-9. 1998
15. Chomczynski P., Sacchi N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159. 1987
16. Ignacio P.C., Baldwin B.A., Vijayan V.K., Tait R.C., Gorin F.A.: Brain isozyme of glycogen phosphorylase: immunohistochemical localization within the central nervous system. Brain Res. 529: 42-49, 1990
17. Tashima S., Shimada S., Yamaguchi K., Tsuruta J., Ogawa M.: Expression of brain-type glycogen phosphrylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas. (submitted)
18. Morson B.C.: Intestinal metaplasia of the gastric mucosa. Br. J. Cancer. 85: 377-385. 1955.
19. Ming S.C., Goldman H., Freiman D.G.: Intestinal metaplasia and histogenesis of carcinoma in human stomach. Cancer 20: 1418-1429. 1967.
20. Stemmermann G.N.: Intestinal metaplasia of the stomach. Cancer 74: 556-564. 1994.
21. Correa P., Shiao Y.: Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res. 54: 1941-1943. 1994
22. Hill M.J.: Mechanisms of gastric carcinogenesis. Eur. J. Cancer Prevent. 3: 25-29. 1994
23. Brito M.J., Filipe M.I., Morris R.W.: Cell proliferation study on gastric carcinoma and non-involved gastric mucosa using a bromodeoxyuridine (BrdU) labeling technique. Eur. J. Cancer Prevent. 1: 429-435. 1992
24. Ranzani G.N., Luinetti O., Padovan L.S., et al.: p53 gene mutation and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol. Biomark. Prevent. 4: 223-231. 1995.
25. Tahara E.: Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 199: 265-272. 1993.
26. Shiao Y., Rugge M., Correa P., Lehmann P., Scheer W.: p53 alteration in gastric precancerous lesion. Am. J. Pathol. 144: 511-517. 1994.
27. UICC. TNM Atlas: An illustrated guide to the TNM/pTN-classification of malignant tumors. 3rd edn. Heidelberg: Springer-Velag, 1993.
28. Morson B.C.: The polyp-cancer sequence in the large bowel. Proc. R. Soc. Med. 67: 451-457. 1974.
29. Fearon E.R., Jones P.A.: Progressing toward a molecular description of colorectal cancer development. FASEB J. 6: 2783-2790. 1992.
30. Vogelstein B., Fearon E.R., Hamilton S.R., et al.: Genetic alterations during colorectal-tumor development. N. Eng. J. Med. 319: 525-532. 1988.
31. Fearon E., Vogelstein B.: A genetic model for colorectal tumorigenesis. Cell 61: 759-767. 1990
32. Shimoda T., Ikegami M., Fujisaki J., Matsui T., Aizawa S., Ishikawa E.: Early colorectal carcinoma with special reference to its development de novo. Cancer 64: 1138-1146. 1989.
33. Minamoto T., Sawaguchi K., Mai M., Yamashita N., Sugimura T., Esumi H.: Infrequent K-ras activation in superficial-type(flat) colorectal adenomas and adenocarcinomas. Cancer Res. 54: 2841-2844, 1994.
34. Yamagata S., Muto T., Uchida Y., et al.: Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas. Jpn. J. Cancer Res. 85: 147-151. 1994.
35. Mueller J., Mueller E., Hoepner I., et al.: Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study. J. Pathol. 180: 259-265. 1996
36. Bird R.P.: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen. Cancer Lett. 37: 147-151. 1987.
37. Pretlow T.P., Barrow B.J., Ashton W.S., O'Riordan M.A., Pretlow T.G., Jureisek J.A., et al.: Aberrant crypts: putative preneoplastic foci in human colonie mucosa. Cancer Res. 51: 564-567. 1991.
38. Shivapurkar N., Huang L., Ruggeri B., Swalsky P.A., Bakker A., Finkelstein S., et al.: K-ras and p53 mutations in aberrant crypt foci and colonie tumors from colon cancer patients. Cancer Lett. 115: 39-46. 1997.